IRIS - Res&Arch Institutional Research Information System - Research & Archive

RUGGERI, Loredana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.091
EU - Europa 1.712
AS - Asia 573
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
OC - Oceania 1
Totale 4.380
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.090
IE - Irlanda 429
UA - Ucraina 312
IT - Italia 295
SE - Svezia 278
HK - Hong Kong 208
SG - Singapore 131
CN - Cina 129
FI - Finlandia 99
RU - Federazione Russa 78
DE - Germania 76
VN - Vietnam 59
GB - Regno Unito 51
FR - Francia 20
KR - Corea 17
BE - Belgio 15
CH - Svizzera 11
TR - Turchia 11
CZ - Repubblica Ceca 9
GR - Grecia 8
NL - Olanda 8
AT - Austria 7
LB - Libano 7
RO - Romania 7
PL - Polonia 6
UZ - Uzbekistan 4
IN - India 3
BG - Bulgaria 2
EU - Europa 2
AU - Australia 1
CA - Canada 1
EE - Estonia 1
GE - Georgia 1
JO - Giordania 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 4.380
Salva come PNG Salva come JPEG
Città #
Chandler 443
Dublin 429
San Mateo 287
Hong Kong 207
Boardman 156
Jacksonville 150
Perugia 118
Singapore 88
Medford 82
Princeton 82
Altamura 71
Ann Arbor 70
Wilmington 64
Andover 63
Dong Ket 59
Lawrence 55
Beijing 48
Des Moines 30
Saint Petersburg 24
Helsinki 22
Woodbridge 21
Norwalk 20
Ashburn 17
Redwood City 17
Shanghai 15
Foligno 13
Los Angeles 13
San Paolo di Civitate 13
Houston 12
Seoul 12
Brussels 11
Munich 11
Izmir 10
Dallas 9
New York 9
Redmond 8
Bucharest 7
Moscow 7
Brno 6
Chicago 6
Ancona 5
Auburn Hills 5
Den Haag 5
Falls Church 5
Florence 5
Rome 5
Santa Clara 5
Dearborn 4
Deruta 4
Philadelphia 4
West Jordan 4
Zaventem 4
Amsterdam 3
Aurora 3
Mirano 3
Padova 3
Prata Di Pordenone 3
San Diego 3
Vienna 3
Bologna 2
Bupyeong-gu 2
Eunpyeong-gu 2
Falkenstein 2
Guangzhou 2
Nanning 2
Naples 2
Oklahoma City 2
Olomouc 2
Simi Valley 2
Stockholm 2
Valenza 2
Athens 1
Atlanta 1
Castelnuovo Berardenga 1
Chengdu 1
Collazzone 1
Dong-gu 1
Edinburgh 1
Göteborg 1
Hangzhou 1
Hanover 1
Hefei 1
Hyderabad 1
Jesi 1
Johannesburg 1
Kocaeli 1
Kunming 1
Lappeenranta 1
Latina 1
Lonate Ceppino 1
London 1
Mogliano 1
Nanjing 1
Orlando 1
Ottawa 1
Phoenix 1
Ponso 1
Port Saint Lucie 1
Porto Mantovano 1
Riyadh 1
Totale 2.914
Salva come PNG Salva come JPEG
Nome #
Innate immunity against hematological malignancies 100
Effects of anti-NKG2A antibody administration on leukemia and normal hematopoietic cells 96
Allogeneic hematopoietic transplantation and natural killer cell recognition of missing self. 88
Alloreactive natural killer cells in mismatched hematopoietic stem cell transplantation 86
Loss of matrix metalloproteinase 2 in platelets reduces arterial thrombosis in vivo. 80
The NOTCH1/CD39 axis: A Treg trip-switch for GvHD 79
Natural killer cell recognition of missing self and haploidentical hematopoietic transplantation. 74
. G-CSF blocks IL-12 productin by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation. 73
G-CSF blocks IL-12 production by antigen presenting cells: implications for improved immune reconstitution after haploidentical hematopoietic transplantation.. 72
Addition of PBPCs to the marrow inoculum allows engraftment of mismatched T cell-depleted transplants for acute leukemia 70
Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation. 69
Natural killer cells: biology and application in stem-cell transplantation 68
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 68
Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. 67
Haploidentical transplantation and natural killer cell recognition of missing self. 66
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 66
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces nonrelapse mortality 66
Early intrathecal infusion of everolimus restores cognitive function and mood in a murine model of Alzheimer's disease 62
How Adoptive Immunotherapy with Conventional T and Regulatory T Cells Exerts a Gvl Effect without GvHD, after Haploidentical Hematopoietic Transplantation 62
Optimizing a photoallodepletion protocol for adoptive immunotherapy after haploidentical SCT. 61
Immunotherapy with alloreactive natural killer cells in haploidentical haematopoietic transplantation. 60
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 60
Natural killer cell alloreactivity for leukemia therapy. 60
Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants 59
A novel mutation of indoleamine 2,3-dioxygenase 1 causes a rapid proteasomal degradation and compromises protein function 59
Cellular therapy: exploiting NK cell alloreactivity in transplantation 58
Natural killer cell alloreactivity and haplo-identical hematopoietic transplantation. 57
Full haplotype-mismatched hematopoietic stem-cell transplantation: A phase II study in patients with acute leukemia at high risk of relapse 57
A revised NOTCH1 mutation frequency still impacts survival while the allele burden predicts early progression in chronic lymphocytic leukemia 57
Clinical impact of natural killer cell reconstitution after allogenic hematopoitic transplantation.Immunobiology working Party of the European Group for Blood and Marrow Transplantation 57
Involvement of Cd44 Variant Isoforms In Hyaluronate Adhesion By Human Activated T-cells 56
Alloreactive natural killer cells for the treatment of acute myeloid leukemia: From stem cell transplantation to adoptive immunotherapy 56
"Designed" grafts for HLA-haploidentical stem cell transplantation. 55
Donor activating KIR genes and control of infections after haploidentical haematopoietic transplantation 55
Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation 54
The Total Body Irradiation Schedule Affects Acute Leukemia Relapse After Matched T Cell–Depleted Hematopoietic Stem Cell Transplantation 54
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 54
HLA-haploidentical transplantation with regulatory and conventional T-cell adoptive immunotherapy prevents acute leukemia relapse 54
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells. 51
Preclinical characterization of 1-7F9,a novel human anti-KIR receptor therapeutic antibody that augments natural kille-mediated killing of tumor cells. 51
Haploidentical hematopoietic transplantation for the cure of leukemia: from its biology to clinical translation. 51
Role of Natural Killer Cell Alloreactivity in HLA-Mismatched Hematopoietic Stem Cell Transplantation 50
Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value. 49
New mechanism of lymphoma-induced bone marrow aplasia 49
Human leukocyte antigens A23, A24, and A32 but not A25 are ligands for KIR3DL1. 47
NCRs and DNAM-1 mediate NK cell recognition and iysis of human and mouse melanoma cell lines in vitro and in vivo 47
Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor. 46
null 46
Natural killer cell alloreactivity in haploidentical hematopoietic stem cell transplantation 46
Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation. 46
Natural killer cell allorecognition of missing self in allogenic hematopoietic transplantation :a tool for immunotherapy of leukemia. 45
Transplantation for high-risk acute leukemia with high doses of T cell-depleted hematopoietic stem cells from haploidentical “three loci” incompatible donors. 44
Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. 44
Postgrafting administration of granulocyte colony-stimulating factor impairs functional immune recovery in recipients of human leukocyte antigen haplotype-mismatched hematopoietic transplants 43
Identifying NK alloreactive donors for haploidentical hematopoietic stem cell transplantation 43
Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect 42
Jack of all trades: thymosin α1 and its pleiotropy. 42
Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants 42
Striking survival advange of bad-risk acute myeloid leukemia patients transplanted from haploidentical donors with KIR epitope incompatibility in the GVH direction 42
The “ultimate” haploidentical transplantation for the elderly with high-risk acute myeloid leukemia 41
Post-grafting granulocyte colony-stimulating factor administration impairs functional immune recovery in recipients of HLA haplotype-mismatched hematopoietic transplants 40
Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells 40
Clinical impact of natural killer cell reconstitution after allogeneic hematopoietic transplantation. 40
Larger size of donor alloreactive NK cell repertoire correlates with better response to NK cell immunotherapy in elderly acute myeloid leukemia patients 40
Enhancing Regulatory T Cell Function and Homing to the Gut to Improve graft-versus-host Disease Prevention after Adoptive Transfer in Allogeneic Hematopoietic Transplantation 39
Immunoselection and clinical use of T regulatory cells in HLA-haploidentical stem cell transplantation. 39
Natural Killer (NK)-Cell Function and Anti-Leukemic Activity of a Large Population of CD3+/CD8+ T Cells Expressing NK Receptors for MHC Class I after “Three-Loci” HLA-Incompatible Bone Marrow Transplantation 38
Natural killer-cell KIR repertoire reconstitution after haploidentical SCT. 38
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 38
Natural killer cell alloreactivity in allogeneic hematopoietic transplantation. 37
The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. 37
null 36
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 36
NK cell alloreactivity and allogeneic hematopoietic stem cell transplantation. 36
Killer-cell immunoglobulin-like receptors reactivity and outcome of stem cell transplant. 36
Haploidentical age-adapted myeloablative transplant and regulatory and effector T cells for acute myeloid leukemia 35
NK cells: a lesson from mismatched hematopoietic transplantation 34
Thymosin Alfa 1 Administration Improves Immune Reconstitution and Decreases Infection-Related Mortality After HLA-Matched Sibling T Cell-Depleted Stem Cell Transplantation. 34
Treatment of high-risk acute leukemia with T-cell-depleted stem cell related donors with one fully mismatched HLA haplotype. 34
CD44 signaling through p56lck involves lateral association with CD4 in human CD4+ T cells 31
Next generation HLA-haploidentical HSCT 29
A Novel t(5;7)(q31;q21)/CDK6::IL3 in Immature T-cell Acute Lymphoblastic Leukemia With IL3 Expression and Eosinophilia 27
Haploidentical hematopoietic transplantation from KIR ligand-mismatched donors with activating KIRs reduces non-relapse mortality 25
Natural killer cell-mediated lysis of autologous cells modified by gene therapy 24
Natural killer cells as a therapeutic tool in mismatched transplantation 24
Donor natural killer cells trigger production of beta-2-microglobulin to enhance post bone marrow transplant immunity 23
Natural killer (NK)-cell function and antileukemic activity of a large population of CD3+/CD8+ T cells expressing NK receptors for major histocompatibility complex class I after "three-loci" HLA-incompatible bone marrow transplantation 22
Natural killer cell activity and killer immunoglobulin-like receptors in hematopoietic stem cell transplantation 22
CAR T cell-driven cerebrospinal fluid cytokine storm with confounding neurological picture in chemorefractory primary cardiac lymphoma 21
Impact of total marrow/lymphoid irradiation dose to the intestine on graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for hematologic malignancies 20
Novel Immune Cell-Based Therapies to Eradicate High-Risk Acute Myeloid Leukemia 19
A pro-inflammatory environment in bone marrow of Treg transplanted patients matches with graft-versus-leukemia effect 17
Blinatumomab Redirects Donor Lymphocytes against CD19+ Acute Lymphoblastic Leukemia without Relevant Bystander Alloreactivity after Haploidentical Hematopoietic Stem Cell Transplantation 17
Polatuzumab‐bendamustine‐rituximab as bridge to CD19‐directed CAR T cells in mantle cell lymphoma refractory to ibrutinib and venetoclax 16
How adoptive transfer of components of the donor immune system boosts GvL and prevents GvHD in HLA-haploidentical hematopoietic transplantation for acute leukemia 15
null 11
Totale 4.572
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020311 0 0 46 7 40 6 47 7 65 37 16 40
2020/2021685 9 59 25 53 203 55 46 7 73 24 56 75
2021/2022873 14 235 29 51 45 5 6 231 10 36 101 110
2022/20231.394 91 258 15 108 97 150 4 67 524 8 53 19
2023/2024652 40 78 24 8 3 9 173 14 61 21 112 109
2024/2025191 23 136 32 0 0 0 0 0 0 0 0 0
Totale 4.572